Found: 8
Select item for more details and to access through your institution.
The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2017, v. 43, n. 4, p. 617, doi. 10.1111/jog.13282
- By:
- Publication type:
- Article
Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2015, v. 41, n. 10, p. 1638, doi. 10.1111/jog.12754
- By:
- Publication type:
- Article
Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1336, doi. 10.1007/s10147-021-01914-y
- By:
- Publication type:
- Article
Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 4, p. 741, doi. 10.1007/s10147-016-0955-3
- By:
- Publication type:
- Article
Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402).
- Published in:
- World Journal of Surgical Oncology, 2017, v. 15, p. 1, doi. 10.1186/s12957-017-1200-x
- By:
- Publication type:
- Article
A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial.
- Published in:
- Journal of Gynecologic Oncology, 2021, v. 32, n. 4, p. 1, doi. 10.3802/jgo.2021.32.e64
- By:
- Publication type:
- Article